Both CD44 and SOX2 CSC-like markers were overexpressed in the C666-1 tumor sphere and the isolated CD44+ NPC cells were found to be more resistant to chemotherapeutic agent[34]. This evidence concerns the gene CD44 and nasopharyngeal carcinoma.